(WSVN) - Over two dozen children’s medicines are being recalled due to a “microbial contamination,” according to the Food and Drug Administration.

King Bio has issued a voluntarily recall for 32 of its children’s medicines after some products tested positive for contamination. The FDA says medications with microbial contamination could result in increased infections, which may be life-threatening for some patients.

The company said the recall is out of an abundance of caution, noting it has not received any reports of injury or illness to date due to the contamination.

The affected medicines were produced between August of 2017 and April of 2018.

The following products are being recalled by King Bio:

  • DK Attention & Learning Enh.
  • Chicken Pox Symptom Relief
  • Children’s Appetite & Weight
  • Children’s Appetite Enhance
  • Children’s Cough Relief
  • Children’s Fever Reliever
  • Children’s Growth & Development
  • DK Newborn Tonic
  • DK Nosebleed Relief
  • TonsilPlex
  • Children’s Ear Relief Formula
  • DK Teething
  • DK Colic Relief
  • Tummy Aches
  • Kids Multi-Strain Flu Relief
  • Kids Stress & Anxiety
  • Kids Sleep Aid
  • Kids Bed Wetting (NP)
  • Kids Candida 4 oz
  • Kids Attention & Learning (SCRX)
  • Bed Wetting Prevention (SCRX)
  • Chicken Pox Symptom Relief (SCRX)
  • Children’s Cough (SCRX)
  • Children’s Ear Formula (SCRX)
  • Children’s Fever Reliever (SCRX)
  • Children’s Growth & Development (SCRX)
  • Colic Relief (SCRX)
  • Newborn Tonic (SCRX)
  • Teething (SCRX)
  • Tummy Aches (SCRX)
  • Children’s Appetite & Weight (SCRX)
  • Children’s Appetite Enhancer (SCRX)

Click here to view the specific lot numbers being recalled.

Consumers with questions regarding the recall can contact King Bio at (866) 298-2740 or at recall@kingbio.com. The FDA says parents should contact their physician or healthcare provider if their children have experienced any problems that may be related to taking or using these products.

Copyright 2024 Sunbeam Television Corp. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Join our Newsletter for the latest news right to your inbox